‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply

Detalles Bibliográficos
Autores principales: Broman, Niklas, Feuth, Thijs, Oksi, Jarmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250883/
https://www.ncbi.nlm.nih.gov/pubmed/35798145
http://dx.doi.org/10.1016/j.cmi.2022.06.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250883/
https://www.ncbi.nlm.nih.gov/pubmed/35798145
http://dx.doi.org/10.1016/j.cmi.2022.06.028

Ejemplares similares